FIELD: medicine.
SUBSTANCE: invention refers to chemical-pharmaceutical industry, and medicine, namely to a new hypolipidemic preparation representing a molecular complex of atorvastatin and β-glycyrrhizic acid at the mole ration of atorvastatin: β-glycyrrhizic acid 1: (1-4).
EFFECT: invention exhibits high efficiency with much smaller dosage than initial atorvastatin.
5 ex, 2 dwg, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
MEDICINAL AGENT "SIMVAGLISIN" WITH HYPOLIPIDEMIC EFFECT | 2006 |
|
RU2308947C1 |
HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC AGENT | 2007 |
|
RU2372923C2 |
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HYPERLIPIDEMIA | 2017 |
|
RU2683641C2 |
PHARMACEUTICAL COMPOSITION FOR HYPERLIPIDEMIA TREATMENT | 2014 |
|
RU2623876C2 |
AGENT WITH HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC ACTION | 2008 |
|
RU2372897C1 |
METHOD FOR CORRECTION OF LIPOPEROXIDATION ACCOMPANYING HYPOLIPIDEMIC THERAPY OF PATIENTS WITH METABOLIC SYNDROME | 2011 |
|
RU2458687C1 |
AGENT POSSESSING HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC ACTIVITY | 2015 |
|
RU2598347C1 |
HYPOLIPIDEMIC AGENT | 2008 |
|
RU2392933C2 |
METHOD FOR TREATING CHOLELITHIASIS PATIENTS FOR HYPERCHOLESTEROLEMIA STATES BY ADMINISTERING HEPATOSAN PREPARATION ACCELERATING CHOLESTEROL OXIDATION IN LIVER | 2006 |
|
RU2306943C1 |
AGENT FOR METABOLIC SYNDROME CORRECTION | 2011 |
|
RU2458935C1 |
Authors
Dates
2010-08-10—Published
2008-12-03—Filed